Cystatin Antibodies

Santa Cruz Biotechnology features a diverse variety of Cystatin Antibodies for investigating the role of cystatins in various biological processes. Cystatin Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cystatins are a family of cysteine protease inhibitors that regulate proteolytic activity in cells, influencing processes such as apoptosis, inflammation, and tissue remodeling. Research has shown that cystatins are involved in various diseases, including cancer and neurodegenerative disorders, making them important targets for therapeutic intervention. Scientists worldwide use cystatin monoclonal antibodies to study protein-protein interactions and cellular signaling pathways. Current research focuses on understanding how cystatins contribute to disease progression and potential treatment strategies. Ongoing studies explore the relationship between cystatin expression levels and various pathological conditions. The extensive selection of monoclonal cystatin antibodies from Santa Cruz Biotechnology enables researchers to advance scientific understanding of disease mechanisms and potential therapeutic approaches.